What is Smoldering Multiple Myeloma?

SMM is characterized by an M-protein value more than 3 g/dL or more than 10% plasma cells in the bone marrow. Affected patients have no lytic lesions, anemia, or hypercalcemia.

Taken from Dr. Kyle's Overview of Multiple Myeloma, presented at the IMF Patient & Family Interactive Seminar in Ft. Lauderdale, FL January, 2004.

Search This Site

Tax Deductible Donation

Please support this site and online support for health challenges of all kinds, which are provided by the Online Patient Empowerment Project, a 501(c)(3) Corporation.

Search the Web

Mailing Lists

Have you subscribed to the MMA interactive mailing list? Please click HERE to subscribe. Once subscribed, you can choose a daily digest version, real time delivery and you'll have access to the list archives. To join the ACOR list, please click HERE.

Syndicate

Statistics

Visitors: 693079

Main Menu

Contributions

Information

Login

Please Visit